COMMUNIQUÉS West-GlobeNewswire

FIT Biotech Oy: Conversion of FIT Biotech Oy's Convertible Capital Notes into shares

18/10/2017 - 09:00

FIT Biotech Oy Company release October 18, 2017 at 10:00 AM EET Conversion of FIT Biotech Oy's Convertible Capital Notes into shares Related to Convertible Note and Warrant Programmes established on September 26, 2016 [...]

Photocure ASA: FDA grants priority review for Cysview® supplemental New Drug Application (sNDA)

18/10/2017 - 08:15

Oslo, Norway, October 18, Photocure ASA (OSE: PHO) announced today that the U.S. Food and Drug Administration (FDA) has accepted the supplemental New Drug Application (sNDA) for Cysview ® on a priority review basis. [...]

Novartis drug Revolade® shows long-term disease control for chronic/persistent immune thrombocytopenia (ITP)

18/10/2017 - 07:15

Nearly 70% of patients maintained platelet counts of >=30×10 9 /L without rescue therapy for prolonged periods, reducing the overall risk of bleeding More than one-third of patients permanently stopped one or more [...]

MedDay to Participate in the 7th Joint ECTRIMS - ACTRIMS Meeting in Paris, France

18/10/2017 - 07:00

MedDay to Participate in the 7 th Joint ECTRIMS - ACTRIMS Meeting in Paris, France Sponsors a satellite symposium: 'New horizons in progressive multiple sclerosis' Oral presentation of 24-month MRI data from MS-SPI [...]

World Conference on Lung Cancer Wednesday Press Conference: PD-1/PD-L1 Advancements and Interventions to Prevent and Treat Lung Cancer

18/10/2017 - 06:24

YOKOHAMA, Japan, Oct. 18, 2017 (GLOBE NEWSWIRE) -- The final press conference from the International Association for the Study of Lung Cancer (IASLC) 18th World Conference on Lung Cancer (WCLC) highlighted new [...]

Weifa ASA - minutes of extraordinary general meeting

17/10/2017 - 17:45

Following the compulsory acquisition of the remaining shares in Weifa ASA that was effected on 12 October 2017, an extraordinary general meeting was held on 17 October 2017 in Weifa ASA. Please find attached the minutes [...]

DBV Technologies : Information mensuelle relative au nombre total des droits de vote et d'actions composant le capital social

17/10/2017 - 17:00

Information mensuelle relative au nombre total des droits de vote et d'actions composant le capital social (Article 223-16 du Règlement Général de l'Autorité des Marchés Financiers) Place de cotation : NYSE Euronext [...]

DBV Technologies : Monthly information regarding the total number of voting rights and total number of shares of the Company

17/10/2017 - 17:00

Monthly information regarding the total number of voting rights and total number of shares of the Company (Article 223-16 of the General Regulations of the Autorité des Marchés Financiers ) Market : NYSE Euronext Paris [...]

Conférence de presse du lundi à l'occasion de la Conférence mondiale sur le cancer du poumon : Recherches sur les dangers du tabagisme et les interventions du cancer du poumon

17/10/2017 - 16:35

YOKOHAMA, Japon, le 17 octobre 2017 (GLOBE NEWSWIRE) - Lors de la conférence de presse organisée aujourd'hui à l'occasion de la 18 e Conférence mondiale sur le cancer du poumon (World Conference on Lung Cancer - WCLC) [...]

Crown Bioscience to Showcase Scientific Expertise in Preclinical Evaluation of Investigational Cancer Compounds

17/10/2017 - 16:11

SANTA CLARA, Calif., Oct. 17, 2017 (GLOBE NEWSWIRE) -- Crown Bioscience , a wholly-owned subsidiary of Crown Bioscience International (TWSE:ticker 6554) and a global drug discovery and development services company [...]

PCI Biotech: Employee share option scheme

17/10/2017 - 16:01

Oslo, 17 October 2017 In accordance with the authorisation granted by the Annual General Meeting 29 May 2017, the Board of Directors of PCI Biotech Holding ASA has awarded a total of 90,000 share options to key [...]

Saniona AB: Saniona's Partner Cadent Therapeutics Receives Milestone from Novartis

17/10/2017 - 14:15

PRESS RELEASE October 17, 2017 Saniona, a leading biotech company in the field of ion channels, today announced that its collaboration partner, Cadent Therapeutics (former Luc Therapeutics), has earned a milestone [...]

ProMIS Neurosciences Lead Product Candidate, PMN310, Shows Desired Target Binding Profile in Direct Comparison to Other Amyloid Beta-Directed Antibodies for Alzheimer's Disease

17/10/2017 - 13:30

Narrated presentation of results available on ProMIS website TORONTO and CAMBRIDGE, Mass., Oct. 17, 2017 (GLOBE NEWSWIRE) -- ProMIS Neurosciences, Inc., a biotechnology company focused on the discovery and development [...]

Terveystalo Plc's ten largest shareholders after the completion of the Initial Public Offering

17/10/2017 - 13:30

TERVEYSTALO PLC STOCK EXCHANGE RELEASE October 17, 2017 at 2:30 p.m. NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO AUSTRALIA, CANADA, THE HONG KONG SPECIAL [...]

ABLYNX ANNOUNCES LAUNCH OF PROPOSED GLOBAL OFFERING

17/10/2017 - 13:29

pdf version of press release This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients. The issuer of this announcement warrants that they are solely responsible for [...]

Inivata Highlights New Clinical Data on InVision(TM) ctDNA Liquid Biopsy Platform in advanced NSCLC at WCLC 2017

17/10/2017 - 13:00

Inivata Highlights New Clinical Data on InVision(TM) ctDNA Liquid Biopsy Platform in advanced NSCLC at WCLC 2017 First data published using amplicon-based technology to detect ALK and ROS1 fusions Highly sensitive [...]

Arix Bioscience PLC: Appoints Giles Kerr to Board of Directors

17/10/2017 - 13:00

Arix Bioscience appoints Giles Kerr to Board of Directors LONDON, 17 October 2017: Arix Bioscience plc (LSE: ARIX) ("Arix Bioscience" or "the Company"), a global healthcare and life science company supporting medical [...]

World Conference on Lung Cancer Tuesday Press Conference: Evidence to Support Innovative Lung Cancer Interventions

17/10/2017 - 08:30

YOKOHAMA, Japan, Oct. 17, 2017 (GLOBE NEWSWIRE) -- Today's press conference at the International Association for the Study of Lung Cancer (IASLC) 18 th World Conference on Lung Cancer (WCLC) featured groundbreaking [...]

RÉALISATION DE L'ÉMISSION PAR GENFIT D'OBLIGATIONS À OPTION DE CONVERSION ET/OU D'ÉCHANGE EN ACTIONS NOUVELLES ET/OU EXISTANTES (« OCEANE ») A ÉCHÉANCE 2022 POUR UN MONTANT DE 180 MILLIONS D'EUROS

17/10/2017 - 08:30

REALISATION DE L'EMISSION PAR GENFIT D'OBLIGATIONS A OPTION DE CONVERSION ET/OU D'ECHANGE EN ACTIONS NOUVELLES ET/OU EXISTANTES (« OCEANE ») A ECHEANCE 2022 POUR UN MONTANT DE 180 MILLIONS D'EUROS Lille (France), [...]